European Commission approves Camurus' once-monthly octreotide treatment for acromegaly

Genenta Science reports long-term survival signals in glioblastoma study as genitourinary trial advances

Sensorion reports positive early results from first cohort of gene therapy trial for congenital deafness

Amgen's Phase 3 bemarituzumab plus chemotherapy clinical trial meets primary endpoint

TuHURA Biosciences acquires Kineta

AbbVie agrees to acquire Capstan Therapeutics

Tyra Biosciences doses first patient in TYRA-300 Phase 2 study for bladder cancer

Alpha Fusion partners with Curadh MTR for global development of Astatine-211 based radiopharmaceuticals

Rocket Pharmaceuticals receives FDA clearance for gene therapy targeting BAG3-associated dilated cardiomyopathy

argenx advances ARGX-119 to registrational study for congenital myasthenic syndromes

hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results

Sanofi's riliprubart receives orphan drug designation in Japan for CIDP

HUTCHMED gains China approval for ORPATHYS and TAGRISSO combination in lung cancer

Sobi's Gamifant (emapalumab-lzsg) receives US FDA approval to treat macrophage activation syndrome in Still's disease

Hikma Pharmaceuticals USA announces USD1bn of new US investment